The move also reflects the country's support for medical innovation and stronger push for research and development of innovative drugs.
此举还体现了我国对医药创新的支持和对研发创新药的大力推动。
10 of the 17 newly-included drugs have been publicly available since last year.
新纳入医保报销目录的17种药品中有10种为2017年后上市的品种。
【福音!17种抗癌药物纳入医保报销】相关文章:
最新
2019-01-07
2019-01-07
2019-01-07
2019-01-07
2019-01-07
2019-01-05